The Patent Finder

Terms ending in 2035

Cellectis

Every in-force patent on Cellectis's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,778,993New Repeat Variable Diresidues for Targeting Nucleotides
In force
 · High confidence
Cellectis, S.A.In forceHigh confidence
US 10,196,608Method for in Situ Inhibition of Regulatory T Cells
In force
 · High confidence
CellectisIn forceHigh confidence
US 12,252,699Method for Generating T-Cells Compatible for Allogenic Transplantation
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,357,515Method for Generating Batches of Allogeneic T-Cells with Averaged Potency
In force
 · High confidence
CellectisIn forceHigh confidence
US 9,944,709CD123 Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 9,944,702CD33 Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,765,728Method for Generating Immune Cells Resistant to Arginine And/Or Tryptophan Depleted Microenvironment
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,316,101Bcma (CD269) Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,498,971Bcma (CD269) Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,378,007Methods for Modulating Tal Specificity
In force
 · High confidence
Cellectis, S.A.In forceHigh confidence
4 more term ends in 2035 · Pro
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Upgrade to Pro
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited